Trial intelligence / Profile preview

14C-GRT6006 mass balance and metabolite profiling study in healthy men

NL-OMON35855Active, not recruiting

Sponsor
Grünenthal GmbH
Start
May 2011
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of lexanopadol in pain, sponsored by Grünenthal GmbH. Primary endpoint: Pharmacokinetics and excretion balance. Started May 2011; status: active, not recruiting.

02

Drugs

lexanopadol
03

Conditions

pain

Beyond the preview

Go deeper on NL-OMON35855.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON35855.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call